Cardiac Surgery Clinical Trial
— COLCHIRCARDVerified date | February 2017 |
Source | Queen Fabiola Children's University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will compare the clinical efficacy and safety of Volulyte® and Voluven® during elective open-heart surgery in pediatric patients.
Status | Completed |
Enrollment | 88 |
Est. completion date | November 21, 2016 |
Est. primary completion date | November 21, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 3 Years |
Eligibility | Inclusion Criteria: - Age 28 days to 3 years old - Planned cardiac surgery with cardiopulmonary by-pass - signed informed consent Exclusion Criteria: - Moribund patients (ASA 5) - Jehovah Witnesses - Pre-operative coagulation disorders - Pre-operative renal insufficiency - Pre-operative hepatic disorders - Intra-cranial hemorrhage - hypernatremia |
Country | Name | City | State |
---|---|---|---|
Belgium | Hôpital Universitaire Des Enfants Reine Fabiola | Brussels |
Lead Sponsor | Collaborator |
---|---|
Queen Fabiola Children's University Hospital |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Calculated Blood Loss at 3rd Post Operative Day (POD) | 72H post surgery | ||
Secondary | Intraoperative Blood Loss | peri-operative blood losses in ml/kg at the end of surgery | End of surgery, an average of 200 minutes | |
Secondary | Chest Tube Drainage | Total chest tube drainage during Pediatric Intensive Care Unit (PICU) stay | 72H post surgery | |
Secondary | Total Blood Loss | Total blood loss Intraoperative + chest tube drainage during Pediatric Intensive Care Unit (PICU) stay | 72H post surgery | |
Secondary | Exposure to Any Blood Products | Transfusion of any blood product (intraoperative + during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Exposure to Red Blood Cell | Transfusion of Red Blood Cell (intraoperative + during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Red Blood Cell Transfused | Red Blood Cell transfused in transfused patients in ml/kg (intraoperative + during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Exposure to Fresh Frozen Plasma | Transfusion of Fresh Frozen Plasma (intraoperative and during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Fresh Frozen Plasma Transfused | Fresh Frozen Plasma transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Exposure to Platelets | Transfusion of platelets (intraoperative and during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Platelet Transfused | Platelet transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay) | 72H post surgery | |
Secondary | Creatinine | At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery) | ||
Secondary | C-Reactive Protein (CRP) | At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery) | ||
Secondary | PTT | End of surgery, an average of 200 minutes | ||
Secondary | APTT | End of surgery, an average of 200 minutes | ||
Secondary | INR | End of surgery, an average of 200 minutes | ||
Secondary | Fibrinogen | End of surgery, an average of 200 minutes | ||
Secondary | Clotting Time in Seconds | Clotting time on EXTEM ROTEMĀ® | End of surgery, an average of 200 minutes | |
Secondary | Maximal Cloth Firmness | Maximal cloth firmness on EXTEM ROTEMĀ® | End of surgery, an average of 200 minutes | |
Secondary | Creatinine | Post-operative Day 1 | ||
Secondary | CRP | Post-operative Day 1 | ||
Secondary | PTT | Post-operative Day 1 | ||
Secondary | APTT | Post-operative Day 1 | ||
Secondary | INR | Post-operative Day 1 | ||
Secondary | Fibrinogen | Post-operative Day 1 | ||
Secondary | Creatinine | Post-operative Day 2 | ||
Secondary | CRP | Post-operative Day 2 | ||
Secondary | PTT | Post-operative Day 2 | ||
Secondary | APTT | Post-operative Day 2 | ||
Secondary | INR | Post-operative Day 2 | ||
Secondary | Fibrinogen | Post-operative Day 2 | ||
Secondary | Creatinine | Post-operative Day 3 | ||
Secondary | CRP | Post-operative Day 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04051021 -
Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients
|
N/A | |
Recruiting |
NCT04604886 -
The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients
|
N/A | |
Recruiting |
NCT04075981 -
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
|
Phase 3 | |
Completed |
NCT04062396 -
Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction
|
N/A | |
Recruiting |
NCT04709705 -
DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05563662 -
SURgical Registry of ENDocarditis EuRope
|
||
Withdrawn |
NCT03289104 -
Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
|
N/A | |
Completed |
NCT04199039 -
Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction
|
N/A | |
Completed |
NCT03563196 -
Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
|
||
Completed |
NCT02964026 -
Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients
|
N/A | |
Completed |
NCT02471001 -
The Levels of Anaesthetics in Heart Muscle During Heart Surgery
|
N/A | |
Completed |
NCT02325726 -
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
|
N/A | |
Completed |
NCT01246947 -
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
|
N/A | |
Completed |
NCT01151254 -
Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation
|
N/A | |
Completed |
NCT00996099 -
Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients
|
N/A | |
Completed |
NCT00821262 -
Sevoflurane in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT00617955 -
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
|
N/A | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 | |
Completed |
NCT00337805 -
Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
|
Phase 2/Phase 3 |